Subacute bilateral visual loss in methylmalonic acidemia

Journal of Neuro-Ophthalmology

Volumn 31, Issue 4, 2011, Pages 344-346

  Traber, Ghislaine ^a   Baumgartner, Matthias R ^b   Schwarz, Urs ^a   Pangalu, Athina ^a   Donath, Marc Y ^a   Landau, Klara ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CARNITINE; CORTICOSTEROID; UBIDECARENONE;

ADULT; ARTICLE; CASE REPORT; DIET SUPPLEMENTATION; DIET THERAPY; DRUG MEGADOSE; DYSPNEA; FEMALE; GROWTH, DEVELOPMENT AND AGING DISORDERS; HUMAN; HYPOTHERMIA; KIDNEY DYSFUNCTION; LEBER HEREDITARY OPTIC NEUROPATHY; METHYLMALONIC ACIDEMIA; MULTIPLE SCLEROSIS; MUSCLE HYPOTONIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; PRIORITY JOURNAL; VISUAL IMPAIRMENT;

ACUTE DISEASE; AMINO ACID METABOLISM, INBORN ERRORS; BLINDNESS; CARNITINE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASES; YOUNG ADULT;

EID: 81755184309     PISSN: 10708022     EISSN: 15365166     Source Type: Journal    
DOI: 10.1097/WNO.0b013e31822db480     Document Type: Article

References (20)

1. Deodato F, Boenzi S, Santorelli FM, Dionisi-Vici C. Methylmalonic and propionic aciduria. Am J Med Genet C Semin Med Genet. 2006;142C:104-112.
2. Morath MA, Okun JG, Muller IB, Sauer SW, Horster F, Hoffmann GF, Kolker S. Neurodegeneration and chronic renal failure in methylmalonic aciduria - a pathophysiological approach. J Inherit Metab Dis. 2008;31:35-43. (Pubitemid 351384881)
3. Melo DR, Kowaltowski AJ, Wajner M, Castilho RF. Mitochondrial energy metabolism in neurodegeneration associated with methylmalonic acidemia. J Bioenerg Biomembr. 2011;43:39-46.
4. Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, Vercesi AE. Mitochondria and reactive oxygen species. Free Radic Biol Med. 2009;47:333-343.
5. de Baulny HO, Benoist JF, Rigal O, Touati G, Rabier D, Saudubray JM. Methylmalonic and propionic acidaemias: management and outcome. J Inherit Metab Dis. 2005;28:415-423. (Pubitemid 40723875)
6. Ianchulev T, Kolin T, Moseley K, Sadun A. Optic nerve atrophy in propionic acidemia. Ophthalmology. 2003;110:1850-1854. (Pubitemid 37025450)
7. Pinar-Sueiro S, Martinez-Fernandez R, Lage-Medina S, Aldamiz-Echevarria L, Vecino E. Optic neuropathy in methylmalonic acidemia: the role of neuroprotection. J Inherit Metab Dis. 2010; May 7 (epub ahead of print). doi: 10.1007/s10545-010-9084-8.
8. Williams ZR, Hurley PE, Altiparmak UE, Feldon SE, Arnold GL, Eggenberger E, Mejico LJ. Late onset optic neuropathy in methylmalonic and propionic acidemia. Am J Ophthalmol. 2009;147:929-933.
9. Lempp TJ, Suormala T, Siegenthaler R, Baumgartner ER, Fowler B, Steinmann B, Baumgartner MR. Mutation and biochemical analysis of 19 probands with mut0 and 13 with mut? methylmalonic aciduria: identification of seven novel mutations. Mol Genet Metab. 2007;90:284-290. (Pubitemid 46241903)
10. Stromme P, Stokke O, Jellum E, Skjeldal OH, Baumgartner R. Atypical methylmalonic aciduria with progressive encephalopathy, microcephaly and cataract in two siblings - a new recessive syndrome? Clin Genet. 1995;48:1-5.
11. Sadun AA. Mitochondrial optic neuropathies. J Neurol Neurosurg Psychiatry. 2002;72:423-425.
12. Kowaltowski AJ, Seetharaman S, Paucek P, Garlid KD. Bioenergetic consequences of opening the ATP-sensitive K(+) channel of heart mitochondria. Am J Physiol Heart Circ Physiol. 2001;280:H649-H657.
13. Castilho RF, Kowaltowski AJ, Meinicke AR, Bechara EJ, Vercesi AE. Permeabilization of the inner mitochondrial membrane by Ca2+ ions is stimulated by t-butyl hydroperoxide and mediated by reactive oxygen species generated by mitochondria. Free Radic Biol Med. 1995;18:479-486.
14. Spindler M, Beal MF, Henchcliffe C. Coenzyme Q10 effects in neurodegenerative disease. Neuropsychiatr Dis Treat. 2009;5:597-610.
15. DiMauro S, Hirano M, Schon EA. Approaches to the treatment of mitochondrial diseases. Muscle Nerve. 2006;34:265-283. (Pubitemid 44300157)
16. Russo R, Cavaliere F, Rombola L, Gliozzi M, Cerulli A, Nucci C, Fazzi E, Bagetta G, Corasaniti MT, Morrone LA. Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection. Prog Brain Res. 2008;173:575-582.
17. Nucci C, Tartaglione R, Cerulli A, Mancino R, Spano A, Cavaliere F, Rombola L, Bagetta G, Corasaniti MT, Morrone LA. Retinal damage caused by high intraocular pressure-induced transient ischemia is prevented by coenzyme Q10 in rat. Int Rev Neurobiol. 2007;82:397-406.
18. Haas D, Niklowitz P, Horster F, Baumgartner ER, Prasad C, Rodenburg RJ, Hoffmann GF, Menke T, Okun JG. Coenzyme Q (10) is decreased in fibroblasts of patients with methylmalonic aciduria but not in mevalonic aciduria. J Inherit Metab Dis. 2009;32:570-575.
19. Sokol RJ, McKim JMJ, Goff MC, Ruyle SZ, Devereaux MW, Han D, Packer L, Everson G. Vitamin E reduces oxidant injury to mitochondria and the hepatotoxicity of taurochenodeoxycholic acid in the rat. Gastroenterology. 1998;114:164-174. (Pubitemid 28020966)
20. Smith RA, Porteous CM, Coulter CV, Murphy MP. Selective targeting of an antioxidant to mitochondria. Eur J Biochem. 1999;263:709-716. (Pubitemid 29361943)